Abstract
ObjectivesTo prospectively investigate in patients with severe COVID-19-associated cytokine storm syndrome (CSS) whether an intensive course of glucocorticoids with or without tocilizumab accelerates clinical improvement, reduces mortality and prevents invasive...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have